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ABSTRACT 
Objective. Gout is associated with foot pain, impairment and disability.  The aim of 
this study was to assess footwear characteristics and key factors influencing 
footwear choice in patients with gout.  We also wished to evaluate the relationship 
between footwear characteristics and foot disability. 
Methods. Fifty patients with a history of acute gout were recruited from rheumatology 
clinics during the summer months.  Clinical characteristics, global function, and foot 
impairment and disability measures were recorded.  Footwear characteristics and 
the factors associated with choice of footwear were identified using validated 
assessment tools.  Suitability of footwear was assessed using pre-determined 
criteria for assessing adequacy of footwear, based on a previous study of foot pain. 
Results. The patients had moderate to severe foot pain, impairment and disability.  
Poor footwear characteristics included poor cushioning, lack of support, lack of 
stability and motion control.  Over 50% of shoes were ≥12 months old and 
demonstrated excessive wear patterns. Patients reported comfort (98%), fit (90%), 
support (79%) and cost (60%) as important factors in choosing their own footwear.  
No correlation was found between footwear characteristics (length and width) and 
foot characteristics (foot pain, impairment and disability).  Patients with poor footwear 
reported higher foot-related impairment and disability. 
Conclusion. Use of poor footwear is common in patients with chronic gout and is 
associated with foot disability and impairment.   
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Significance and Innovations 
 
• Poor footwear is a major problem in patients with gout 
• Foot pain, impairment and disability may contribute to the problem. 
• Patients reported comfort, fit, support and cost as important factors in 
choosing their own footwear. 
• Future research should be focused on assessing the role of competitively 
priced footwear with adequate cushioning, motion control and sufficient width 
at the forefoot. 
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INTRODUCTION 
Gout is the most prevalent inflammatory arthropathy in men, caused by formation of 
monosodium urate crystals in joints and other tissues (1). Gout typically presents as 
recurrent self-limiting flares of acute joint inflammation, and in the presence of 
persistent hyperuricaemia, chronic tophaceous disease may also develop (2). Gout 
displays a striking predilection to affect the feet, particularly the first 
metatarsophalangeal joint (1st MTPJ), midfoot and ankle (3-6).  We have recently 
reported that patients with chronic gout have changes in gait parameters focused on 
the midfoot and the hallux, consistent with a pain avoidance strategy (7). It is likely 
that these gait changes contribute to altered loading patterns and impaired foot 
function in chronic gout.   
 
Footwear has been developed and modified to provide protection from the 
environment, conform to fashion, assist function, accommodate foot deformities, and 
treat musculoskeletal injury (8). Various footwear characteristics have been linked to 
the development of musculoskeletal disorders such as osteoarthritis of the foot and 
knee, low back pain, foot ulceration, hallux valgus and hammer toes (8). Poorly fitting 
shoes have also been linked to foot pain in rheumatoid arthritis (9, 10). In addition to 
shoe features, previous studies have reported that the individual fit of a shoe is 
important; loose-fitting shoes can also cause excessive foot slippage within the shoe 
during walking, altered contact area between the foot and shoe, impairing foot 
stability and walking parameters (11-13).  
 
To date, the choice of footwear and factors impacting on the choice of footwear have 
been not been reported in patients with chronic gout. The aim of this study was to 
assess footwear characteristics and key factors influencing footwear choice in 
patients with gout.  We also wished to examine the relationships between footwear 
and foot characteristics (pain, disability and impairment). 
 
PATIENTS AND METHODS 
This was a cross-sectional observational study of fifty adult patients with a history of 
gout attacks recruited from rheumatology outpatient clinics at Auckland and Counties 
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Manukau District Health Boards, Auckland, New Zealand.  All patients had a 
physician diagnosis of gout and a history of acute gout according to ACR 
classification criteria (14).  Ethical approval was obtained by Northern X Ethics 
Committee, Auckland, New Zealand (NTX/10/EXP/231) and local institutional 
approval was also obtained.  Participants were excluded if they were experiencing 
an acute gout flare at the time of assessment or had lower limb amputation.  Patients 
with diabetes or neurological disease associated with gout were not excluded from 
the study. A single podiatrist (MF) assessed all patients at a single study visit.  
 
The following data were collected: age, gender, ethnicity, body mass index (BMI), 
disease duration, current pharmacological management, and history of 
cardiovascular disease and diabetes. Foot type was assessed using the Foot 
Posture Index which is a validated method for quantifying standing foot type with 
scores above +4 suggest a flat-foot type (15).  
 
Disease impact was measured using the Leeds Foot Impact Scale (16). This self-
administered questionnaire comprises two subscales for impairment/footwear 
(LFISIF) and activity limitation/participation restriction (LFISAP). The former contains 
21 items related to foot pain and joint stiffness as well as footwear related 
impairments and the latter contains 30 items related to activity limitation and 
participation restriction. Turner (17) reports that a LFISIF >7 point and LFISAP >10 
point as a high to severe level of foot impairment and disability. 
 
Foot pain was assessed using the Foot Function Index domain (17). The FFI is a 
self-administered questionnaire consisting of 23 items grouped in three domains: 
foot pain (nine items), disability (nine items) and functional limitation (five items). All 
items are rated using 100mm visual analogue scales, and higher scores indicate 
greater pain, disability and limitation of activity and thus poorer foot health (18). 
 
An objective assessment of footwear was conducted by the examiner to ascertain 
the type, structural components and fit of the participant’s footwear at the time of the 
study visit (8).  Patients did not receive any instructions about their footwear prior to 
the study visit.  Six aspects of footwear are evaluated and include: (i) fit (length, 
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width and depth); (ii) general (age of shoe, footwear style, weight and length); (iii) 
general structure (heel height, fixation, forefoot height, forefoot sole flexion point, and 
last); (iv) motion control properties (density, fixation, heel counter stiffness, midfoot 
sole sagittal and frontal stability); (v) cushioning (presence lateral, medial and heel 
sole hardness); (vi) wear patterns (upper, midsole, tread and outsole wear pattern).  
 
Based upon previous studies of patients with foot pain and rheumatoid arthritis, we 
classified current footwear into poor, average and good footwear (10,20). The poor 
footwear group consisted of footwear that lack support and sound structure, 
including sandals, flip-flops, slippers, mules and moccasins. The average footwear 
group included shoes such as hard-or-rubber-soled shoes and work boots. The good 
footwear group consisted of athletic shoes, walking shoes, therapeutic footwear and 
Oxford-type shoes. Foot dimensions (foot length and width) were measured using a 
Brannock measuring device (Liverpool, New York, USA). The device allows the 
weight-bearing measurement of foot length and width. Each patient was also asked 
by the examiner to identify the most important feature on a validated check-list that 
included: comfort, style, fit, sole, costs, weight and colour (21).  
 
All analyses were performed using SPSS V17.0. Gender, ethnicity, clinical 
characteristics such as current pharmacological management, history of 
hypertension, cardiovascular disease, diabetes, renal impairment and general 
footwear scores are described as n (percentages).  All other demographic 
characteristics are described as the mean (SD). The association of changes with foot 
characteristics (pain, disability and impairment) with footwear characteristics (shoe 
length and width) were evaluated using Spearman’s ρ correlation coefficients. We 
examined significant differences between shoe category (good, poor and average) 
and foot characteristics (pain, disability and impairment) using one-way ANOVA. We 
undertook secondary analysis using independent t-tests to evaluate significant 
differences in all footwear characteristics between participants with diabetes and 
those without diabetes. All tests were two tailed and P < 0.05 was considered 
significant. 
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RESULTS 
Clinical and foot characteristics 
The clinical and foot characteristics are summarised in Table 1. Patients were 
predominantly middle-aged males with longstanding disease. Obesity and 
cardiovascular disease were common comorbidities.  The majority of patients (n=27, 
58%) had a low-foot profile (flatfoot). Patients had high to severe (LFISIF >7 points 
(n=27, 52%), LFISAP >10 points, n=30, 60%) levels of foot impairment and disability 
(Table 1). The Foot Function Index, pain domain illustrated a moderate level of pain.   
 
Footwear assessment 
Table 2 summarises the footwear types observed.  Overall, 28 (56%) of patients 
wore good footwear that included walking, athletic and Oxford-type shoes, with 42% 
of patients wearing shoes that were defined as ‘poor’. No participants wore high-
heeled shoes. 
 
Table 3 describes footwear characteristics. Footwear characteristics demonstrated 
that shoes were frequently either too long or too short. A similar finding was also 
found for shoe width, although shoe depth was deemed good in over 62% of 
patients. We found that 23% (n=12) of shoes had no fixation. Over 60% (n=30) of 
shoes demonstrated no cushioning and only 36% (n=18) of shoes with heel/forefoot 
cushioning. Minimal motion control properties was found in the current study with 
only 26% (n=13) wore shoes that had adequate heel counter stiffness, 50% (n=25) 
of shoes with midfoot sole sagittal stability and a further 42% (n=21) with midfoot 
sole frontal stability. We observed that 64% (n=32) of patients wore shoes with a 
heel height ranging between 2.6-5.0cm; of those 13 (41%) wore athletic shoes, 9 
(28%) wore Oxford-type shoes, 7 (22%) wore open shoes, 2 (6%) wore bespoke 
footwear and 1 (3%) wore boots. Forefoot sole flexion point demonstrated 54% 
(n=27) of shoes before the level of the 1st MPTJ.  Over half of patients wore shoes 
that were aged over 12 months old.  
 
Table 4 describes the factors patients perceived as important; most commonly 
identified factors were comfort (98%), fit (90%), support (79%), cost (60%) and 
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weight (63%). Patients reported style (36%) and colour (33%) as being less 
important.  
 
Factors influencing changes in foot characteristics and footwear 
Shoe width and depth did not correlate with foot pain, impairment and disability (data 
not shown). However, patients with poor footwear reported higher foot-related 
impairment and activities, particularly in the scores of the LSISAP (p = 0.01) and the 
Foot Function Index, impairment domain (p = 0.02) (Table 5). Secondary analysis 
demonstrated no significant differences in any of the footwear characteristics 
between participants with diabetes (n=7) and those without diabetes (n=43) (p > 
0.05). 
 
DISCUSSION 
The aim of this study was to identify current footwear styles, footwear characteristics, 
and factors that influence footwear choice experienced by patients with chronic gout. 
Overall, we found severe impairment and limited activity scores, consistent with 
significant foot disability and impairment associated with gout.  A previous study has 
reported similar findings of foot pain, impairment and disability relating to chronic 
gout (7).  
 
Over 40% of patients in the current study wore sandals, moccasins and flip-flops. A 
previous study (22) reported that gait changes were observed in an asymptomatic 
population with wearing flip-flops and suggested that the shoe construction may 
contribute to lower limb leg pain and are counter-productive to alleviating pain. The 
wearing of open-type footwear should be interpreted with caution in the current 
study. It is important to understand that open-type footwear, such as flip-flops and 
sandals are commonly worn in New Zealand. However, wearing open-type footwear 
may reflect the issue of finding appropriate footwear, in particular relating to finding 
footwear that has adequate foot width and length.  
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Analysis of patient footwear illustrated signs of detrimental changes. Minimal motion 
control was found in the current study and since the midfoot is required to form a 
rigid lever during propulsion, footwear instability may contribute to foot problems in 
patients with chronic gout.  The current study found over 50% of shoes with a flexion 
point distal to the level of the first metatarsophalangeal joint (1st MPJ). This may limit 
gait efficiency due to altered kinematics which results from inhibition of normal 1st 
MPJ function (8). We can postulate that a flexion point proximal may jeopardise the 
shoe's stability and may exacerbate the problem of efficient toe-off observed in 
patients with chronic gout (7).  
 
Heel height greater than 2.5cm has been associated with hallux valgus, plantar 
callus, postural instability in older adults [8]. In our study over 40% of those with high 
heel height wore athletic shoes. Athletic shoes vary significantly with midsole 
construction that may use elements of gel, foamed polyurethane, or air chambers 
that serve to aid cushioning [20]. The elevated heel height of athletic shoes may go 
some way to explain the high heel height observed in this study.  
 
The lack of cushioning found in shoes demonstrates the inadequate amount of 
structural support for the foot and lower limb. Wear patterns on the footwear 
provided some indication that they were partially worn and there were considerable 
amount of medial compression signs. The poor midfoot sole stability and poor heel 
counter stiffness found suggests that the current footwear does not stabilise the foot 
during walking. The definition of poor shoes (sandals, slippers and flip-flops) used in 
this study implies a shoe design with poor fit, poor foot posture, and a lack of shock 
absorption characteristics. The lack of shock attenuation has the potential to 
increase loads on plantar tissues, potentially leading to foot pain. Combined with the 
presence of a flatfoot type, patients with gout wear footwear that gives no support or 
cushioning and is prone to be unstable. Hence, footwear that has inadequate 
stability, poor cushioning and limited stability may exacerbate foot pain in patients 
with gout.  
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In the current study the participants reported that fit and comfort were important 
factors in choosing footwear, suggesting that patients with gout may prioritise these 
factors due to their condition. More than half of patients reported cost as a factor 
contributing to their footwear choice.  The wearing of poor shoes may be due to 
financial restrictions when purchasing footwear.  Furthermore, gout is a painful and 
distressing condition that can have a major impact on economically active adults, 
who may be forced to give up work either temporarily or permanently due to their 
condition (23,24). These data highlight the barriers related to costs that patients with 
gout may encounter when purchasing footwear. 
 
We found no relationship between foot length and width with foot pain, disability and 
impairment. Previous studies have found similar findings in older adults with arthritis 
(20) and rheumatoid arthritis (10).  However, we found significant differences 
between shoe fit category and foot characteristics with higher scores associated with 
foot impairment and disability in the poor shoe category. Poor footwear may 
exacerbate the problem. Lindsay (25) reported that patients with gout may impede 
the patients’ lower limb function, particularly with recreational activities. 
 
In the current study we found high mean BMIs indicative of obesity. The findings in 
the patients with gout are consistent with a previous gout study (7). The sustained 
repetition of such loading in these activities make significant demands on the feet in 
normal-weight individuals, and these demands are likely to be magnified in those 
with gout, obesity and poor footwear.  It is possible that the increased demand 
related to obesity, coupled with the structural changes associated with chronic gout 
and poor cushioning and control contributes to foot disability in patients with gout.   
 
This study has several limitations. The study was conducted in the summer and in an 
urban environment, and the results may not be generalisable to other seasons or 
geographic locations. The footwear questionnaire contains both objective and 
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subjective data and not all footwear meet the criteria [8]. For example, open-type 
footwear such as mules, flip-flops and sandals are difficult to assess and do not have 
all the footwear features to evaluate. Furthermore, the category for the subjective 
measure of heel height is based on an arbitrary range (i.e. 0-2.5cm; 2.6-5.0cm and 
>5.0cm). Therefore, future research is needed to develop a more objective measure 
to evaluate of heel height. The current study was cross-sectional and future work 
using prospective studies is needed to evaluate causative relationships before any 
definitive conclusions can be made regarding the role of poor footwear in 
contributing to foot pain, impairment and disability in patients with chronic gout.  We 
did not exclude patients with diabetes from this study. Diabetes is frequently 
associated with gout [26] and this combination may contribute to more severe foot 
problems. These patients were not excluded as we wished to ensure that patients 
with a wide spectrum of disease severity and co-morbidities were included, 
consistent with gout that is managed in clinical practice.  Importantly, sub-analysis of 
patients with and without diabetes did not show major changes between the groups. 
Not all patients in this study had microscopically proven gout. The rates of 
microscopically proven gout are consistent with our previous studies of patients with 
chronic gout [27,28]. Although it is possible that misclassification may have occurred, 
all patients included in the study had a physician diagnosis of gout and also fulfilled 
the ACR diagnostic classification for acute gout.     
 
In summary, patients with chronic gout suffer from foot pain, disability and 
impairment. This study has demonstrated that fit, comfort and costs were perceived 
by patients to be important factors in choosing footwear although patients current 
footwear were objectively poor. Overall, the current footwear demonstrated a lack of 
cushioning, control and stability as well as excessive wear. The majority of shoes 
worn by patients were also over 12-months old. For patients with gout, this might 
explain the problems of purchasing adequate footwear due to foot pain, impairment 
and disability. Based upon the current findings we suggest that footwear should be 
considered in the management plan of patients with gout. Future research should be 
focused on assessing the role of competitively priced footwear with adequate 
cushioning, motion control and sufficient width at the forefoot.  
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Table 1: Clinical and foot characteristics 
Age, years, mean (SD)  63.1 (13.2) 
Male sex, n (%) 42 (84%)  
Ethnicity, n (%) Caucasian, 26 (52%)  
Pacific Island, 13 (26%)  
Maori, 8 (16%)  
Asian, 1 (2%) 
Indian, 2 (4%) 
Disease duration, years, mean (SD) 17.9 (14.4) 
Cardiovascular disease, n (%) 20 (40%) 
Diabetes, n (%) 7 (14%) 
Diuretic use, n (%) 10 (20%) 
Allopurinol use, n (%) 28 (56%) 
Body mass index, kg/m2, mean (SD) 31.9 (7.8) 
Tophi present, n (%) 8 (16%) 
Serum urate, mmol/L, mean (SD) 0.43 (0.14) 
Crystal-confirmed diagnosis, n (%) 18 (36%) 
Foot Posture Index, mean (SD)   4.1 (2.9) 
Leeds Foot Impact Scale (impairment), mean (SD) 8.3 (5.3) 
Leeds Foot Impact Scale (activities), mean (SD) 13.3 (10.7) 
Foot Function Index (pain), mean (SD)   34.0 (28.3) 
Foot Function Index (disability),mean (SD) 33.4 (29.1) 
Foot Function Index (activities), mean (SD) 18.1 (24.7) 
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Table 2: Footwear Type 
 
Footwear suitability Total Footwear type n (%) 
Oxford Shoe 9 (18%) 
Walking Shoe 4 (8%) 
Athletic Shoe 13 (26%) Good 28 (56%) 
Therapeutic Footwear 2 (4%) 
Average 1 (2%) Boot 1 (2%) 
Sandal 6 (12%) 
Flip-flop 7 (14%) 
Slipper 4 (8%) 
Backless Slipper 3 (6%) 
Poor 21 (42%) 
Moccasin 1 (2%) 
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Table 3: Footwear Construction Characteristics 
 
Footwear Variable  n (%) 
Fit of Shoe 
Length 
Good                       
Too short 
Too long 
Width 
Good 
Too narrow 
Too wide 
Depth 
Good 
Too shallow 
 
 
21 (42%) 
12 (24%) 
17 (34%) 
 
20 (40%) 
27 (54%) 
3 (6%) 
 
31 (62%) 
19 (38%) 
Heel Height 
0-2.5cm 
2.6-5.0cm 
>5.0cm 
Forefoot Height 
0-0.9cm 
1.0-2.0cm 
>2.0cm 
 
15 (30%) 
32 (64%) 
3 (6%) 
 
11 (22%) 
33 (66%) 
6 (12%) 
Age 
< 6 months 
6-12 months 
>12 months 
 
17 (34%) 
7 (14%) 
26 (52%) 
Width, mm, mean (SD) 23.7 (2.44) 
Length, mm, mean (SD) 271.6 (18.9) 
Motion Control Properties 
1. Midfoot Sole Sagittal Stability 
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Minimal 
Moderate 
Rigid 
2. Midfoot Sole Frontal Stability 
Minimal 
Moderate 
Rigid 
3. Heel Counter Stiffness 
Not Available 
Minimal 
Moderate 
Rigid 
4. Density 
Single 
Dual 
5. Fixation 
None 
Laces 
Straps/Buckles 
25 (50%) 
16 (32%) 
9 (18%) 
 
21 (42%) 
17 (34%) 
12 (24%) 
 
13 (26%) 
21 (42%) 
 3 (6%) 
13 (26%) 
 
48 (96%) 
2 (4%) 
 
12 (23%) 
21 (44%) 
17 (33%) 
Presence of Cushioning 
None 
Heel 
Heel/forefoot 
 
30 (60%) 
2 (4%) 
18 (36%) 
Forefoot Sole Flexion Point 
At level of 1st MPJT 
Before 1st MPJT 
 
23 (46%) 
27 (54%) 
Wear Patterns 
Upper Wear 
Medial tilt 
Neutral 
Lateral tilt 
Midsole Wear 
 
 
21 (42%) 
27 (54%) 
2 (4%) 
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Medial compression signs 
Neutral 
Lateral compression signs 
Tread Pattern 
Not worn 
Partly worn 
Fully worn 
Outer wear pattern 
None 
Normal 
Lateral 
Medial 
10 (20%) 
37 (74%) 
3 (6%) 
 
14 (28%) 
34 (68%) 
2 (4%) 
 
14 (28%) 
23 (46%) 
4 (8%) 
9 (18%) 
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Table 4: Factors relating to footwear choice (more than one response was 
possible using questionnaire) 
 
Factors  n (%) 
Comfort 47 (98%)  
Fit 43 (90%) 
Support 43 (90%) 
Weight 30 (63%) 
Cost 29 (60%) 
Sole 22 (46%) 
Style 17 (36%) 
Colour 16 (33%) 
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Table 5: Differences between shoe fit category and foot characteristics. 
 
Poor Shoe 
Category 
mean (SD) 
Good Shoe 
Category 
mean (SD) 
p 
value 
Leeds Foot Impact Scale 
(impairment) 
9.9 (6.5) 6.5 (4.5) 0.05 
Leeds Foot Impact Scale 
(activities)  
17.2 (11.3) 8.2 (8.7) 0.01 
Foot Function Index (pain) 43.5 (33.7) 27.4 (22.4) 0.07 
Foot Function Index (impairment) 45.9 (29.2) 24.2 (26.4) 0.02 
Foot Function Index (limitation) 24.3 (25.3) 24.1 (26.4) 0.20 
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